EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review

Yating Niu iD, Jun Zhang, Dianhua Shi, Weibiao Zang, Jianguo Niu

Molecules · 2023

DOI: 10.3390/molecules28135210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2023. Verfasst von Yating Niu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Science, Ningxia Medical University, Yinchuan 750004, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic, non-specific disease of unknown etiology. The disease develops mainly in the rectum or colon, and the main clinical symptoms include abdominal pain, diarrhea, and purulent bloody stools, with a wide variation in severity. The specific causative factors and pathogenesis of the disease are not yet clear, but most scholars believe that the disease is caused by the interaction of genetic, environmental, infectious, immune, and intestinal flora factors. As for the treatment of UC, medications are commonly used in clinical practice, mainly including aminosalicylates, glucocorticoids, and immunosuppressive drugs. However, due to the many complications associated with conventional drug therapy and the tendency for UC to recur, there is an urgent need to discover new, safer, and more effective drugs. Natural compounds with biodiversity and chemical structure diversity from medicinal plants are the most reliable source for the development of new drug precursors. Evidence suggests that glycosides may reduce the development and progression of UC by modulating anti-inflammatory responses, inhibiting oxidative stress, suppressing abnormal immune responses, and regulating signal transduction. In this manuscript, we provide a review of the epidemiology of UC and the available drugs for disease prevention and treatment. In addition, we demonstrate the protective or therapeutic role of glycosides in UC and describe the possible mechanisms of action to provide a theoretical basis for preclinical studies in drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeHumansAnimalsGlycosidesColonImmunosuppressive AgentsRectumDisease Models, Animal

Stichwörter der Autor:innen

epidemiologyglycosidesimmune responseinflammatory responseoxidative stresssignal transductionulcerative colitis

Substanzen

GlycosidesImmunosuppressive Agents

Autor:innen und Institutionen

  • School of Basic Medical Science, Ningxia Medical University, Yinchuan 750004, China.
  • Shandong Academy of Chinese Medicine, Jinan 250014, China.
  • School of Pharmacy, Ningxia Medical University, Yinchuan 750004, China.

ORCID-Profile: Yating Niu

Zitieren

APA

Niu, Y., Zhang, J., Shi, D., Zang, W., & Niu, J. (2023). Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review. Molecules. https://doi.org/10.3390/molecules28135210

Vancouver

Niu Y, Zhang J, Shi D, Zang W, Niu J. Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review. Molecules. 2023. doi:10.3390/molecules28135210

BibTeX
@article{Niu2023,
  author = {Niu, Yating and Zhang, Jun and Shi, Dianhua and Zang, Weibiao and Niu, Jianguo},
  title = {Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28135210}
}
Kostenlos starten →